Synergistic Effect of Sodium Butyrate and Thalidomide in the Induction of Fetal Hemoglobin Expression in Erythroid Progenitors Derived from Cord Blood CD133 + Cells

AUTHORS

Ali Dehghanifard 1 , Saied Kaviani 1 , * , Mehrdad Noruzinia 2 , Masoud Soleimani 1 , Saeid Abroun 1 , Abbas Hajifathali 3 , Ali Akbar Pourfathollah 4 , Yousef Mortazavi 5 , Mohammad Ahmadvand 6 , Maryam Mahmoodinia-Meymand 7 , Zeinab Kaviani 8 , Majid Farshdousti-Hagh 9 , Najmaldin Saki 10

1 Department of Hematology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran

2 Department of Medical Genetics, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran

3 Department of Hematology and Oncology, School of Medical Sciences, Shahid Beheshti University, Tehran, Iran

4 Department of Immunology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran

5 Department of Pathology, Zanjan University of Medical Sciences, Zanjan, Iran

6 Department of Laboratory Sciences, Zahedan University of Medical Sciences, Zahedan, Iran

7 Department of Biology, Stem cell Research Center, Sarem Hospital, Tehran, Iran

8 Department of Internal Medicine, Alborz University of Medical Sciences, Karaj, Iran

9 Laboratory of Hematology and Blood Banking, Tabriz University of Medical Sciences, Tabriz, Iran

10 Thalassemia and Hemoglobinopathy Research Center, Jundi Shapur University of Medical Sciences, Ahvaz, Iran

How to Cite: Dehghanifard A, Kaviani S, Noruzinia M, Soleimani M, Abroun S, et al. Synergistic Effect of Sodium Butyrate and Thalidomide in the Induction of Fetal Hemoglobin Expression in Erythroid Progenitors Derived from Cord Blood CD133 + Cells, Zahedan J Res Med Sci. 2012 ; 14(7):e93309.

ARTICLE INFORMATION

Zahedan Journal of Research in Medical Sciences: 14 (7); e93309
Published Online: December 19, 2011
Article Type: Research Article
Received: June 26, 2011
Accepted: August 29, 2011
READ FULL TEXT

Abstract

Background: The use of drugs with the ability to induce production of fetal hemoglobin as a novel therapeutic approach in treating β-Hemoglobinopathies is considered. γ-globin gene expression inducer drugs including sodium butyrate and thalidomide can reduce additional α-globin chains accumulation in erythroid precursors.
Materials and Methods: In this experimental study, MACS kit was used to isolate CD133+ cells of umbilical cord blood. Further, the effect of two drugs of thalidomide and sodium butyrate were separately and combined studied on the induction of quantitative expression of β-globin and γ-globin genes in erythroid precursor cells derived from CD133+ stem cells in-vitro. For this purpose, the technique SYBR green Real-time PCR was used.
Results: Flow cytometry results showed that approximately 95% of purified cells were CD133+. Real-time PCR results also showed the increased levels of γ-globin mRNA in the cell groups treated with thalidomide, sodium butyrate and combination of drugs as 2.6 and 1.2 and 3.5 times respectively, and for β-globin gene, it is respectively 1.4 and 1.3 and 1.6 times compared with the control group (p<0.05).
Conclusion: The study results showed that the mentioned drug combination can act as a pharmaceutical composition affecting the induction of fetal hemoglobin expression in erythroid precursor cells derived from CD133 + cells.

Fulltext

The full text of this article is available on the PDF file.

References

  • 1.

    The References of this article are available on the PDF file.

  • © 2012, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: